Department of Pharmaceutics, Marathwada Mitra Mandal’s College of Pharmacy, Thergaon (Kalewadi), Pune411033, Maharashtra, India
The 21st century is a challenge for people. Population growth, aging population, generation of new infectious agents, and natural disasters are some of the factors that threaten the status quo of blood transfusions. Artificial blood is designed solely to carry oxygen and carbon dioxide into the body. Depending on the type of blood replacer, it can be produced with a variety of techniques using chemical separation, synthetic production, or recombinant biochemical techniques. The technologies focused on the two major alternatives to blood are perfluorocarbons and hemoglobin-based oxygen carriers (HBOCs). With the availability of blood products, the United States alone is expected to generate more than $ 7.6 billion annually.
Rajnandini Ahire, An Overview on Artificial Blood, Int. J. in Pharm. Sci., 2023, Vol 1, Issue 1, 42-47. https://doi.org/10.5281/zenodo.5655215